These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 1803041)

  • 1. Imipenem-cilastatin monotherapy in severe infections accompanying hematological malignancies.
    Urabe A; Takaku F; Mizoguchi H
    Jpn J Med; 1991; 30(5):420-3. PubMed ID: 1803041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipenem/cilastatin versus piperacillin plus amikacin as empiric therapy in the treatment of febrile episodes in neutropenic patients with haematologic malignancies.
    Vandercam B; Ezzeddine H; Agaliotis D; Gala JL; Gigi J; Wauters G; Michaux JL
    Acta Clin Belg; 1989; 44(2):99-109. PubMed ID: 2800889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ceftazidime versus imipenem-cilastatin as initial monotherapy for febrile neutropenic patients.
    Liang R; Yung R; Chiu E; Chau PY; Chan TK; Lam WK; Todd D
    Antimicrob Agents Chemother; 1990 Jul; 34(7):1336-41. PubMed ID: 2201252
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trimethoprim-sulfamethoxazole plus amikacin as first-line therapy and imipenem/cilastatin as second empirical therapy in febrile neutropenic patients with hematological disorders.
    Engervall PA; Stiernstedt GT; Günther GC; Björkholm MJ
    J Chemother; 1992 Apr; 4(2):99-106. PubMed ID: 1629753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Imipenem/cilastatin as monotherapy in neutropenic patients with fever].
    Fridrik MA; Wahl G; Grafinger-Witt E; Leisch F
    Wien Med Wochenschr; 1988 Nov; 138(21):548-51. PubMed ID: 3201783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Imipenem-cilastatin versus piperacillin-tazobactam as monotherapy in febrile neutropenia.
    Vural S; Erdem E; Gulec SG; Yildirmak Y; Kebudi R
    Pediatr Int; 2010 Apr; 52(2):262-7. PubMed ID: 19744230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical evaluation of imipenem/cilastatin sodium against severe infections complicating hematological disorders and solid tumors].
    Saito H; Furuta S; Nagata A; Yoshizawa S; Nishizawa K; Ichikawa S; Aizawa T; Yoda H; Maruyama D; Koike Y
    Jpn J Antibiot; 1991 Aug; 44(8):899-911. PubMed ID: 1920815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imipenem/cilastatin (Primaxin): evaluation in general surgical practice.
    Chin MJ; Bagshaw PF; Bremner JM
    N Z Med J; 1991 Jan; 104(904):22-3. PubMed ID: 2008258
    [No Abstract]   [Full Text] [Related]  

  • 9. Imipenem/cilastatin versus amikacin plus piperacillin in the treatment of infections in neutropenic patients: a prospective, randomized multi-clinic study.
    Norrby SR; Vandercam B; Louie T; Runde V; Norberg B; Anniko M; Andrien F; Baudrihaye M; Bow E; Burman LA
    Scand J Infect Dis Suppl; 1987; 52():65-78. PubMed ID: 3331044
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Imipenem/cilastatin as secondary therapy for bacterial infections.
    Kono K; Onuki K; Tohara S; Takeda S
    Clin Ther; 1991; 13(4):448-56. PubMed ID: 1933995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imipenem/cilastatin treatment of bacterial meningitis in children.
    Wong VK; Wright HT; Ross LA; Mason WH; Inderlied CB; Kim KS
    Pediatr Infect Dis J; 1991 Feb; 10(2):122-5. PubMed ID: 2062603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tigecycline monotherapy vs. imipenem/cilastatin in Chinese patients with complicated intra-abdominal infections: a randomized controlled trial.
    Chen Z; Wu J; Zhang Y; Wei J; Leng X; Bi J; Li R; Yan L; Quan Z; Chen X; Yu Y; Wu Z; Liu D; Ma X; Maroko R; Cooper A
    BMC Infect Dis; 2010 Jul; 10():217. PubMed ID: 20663130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of imipenem/cilastatin in neutropenic patients with haematological malignancies.
    Janmohamed RM; Leyland MJ; Kelly J; Farrell I
    J Antimicrob Chemother; 1990 Mar; 25(3):407-12. PubMed ID: 2338419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ceftriaxone versus imipenem/cilastatin as empirical monotherapy for infections in cancer patients.
    Bucaneve G; Menichetti F; Minotti V; Pasticci MB; Tonato M; Del Favero A
    Chemotherapy; 1989; 35 Suppl 2():10-5. PubMed ID: 2612235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical evaluation of imipenem/cilastatin sodium in infectious complications of hematological malignancies. Tohkai Research Group on Infections in Hematological Disorders].
    Naito K; Kobayashi M; Okumura M; Ikeda Y; Mitomo Y; Oguri T; Tanaka M; Ohara K; Kodera Y; Ohno R
    Jpn J Antibiot; 1990 Aug; 43(8):1371-80. PubMed ID: 2283705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severe gram-negative infections in neutropenic children cured by imipenem/cilastatin in combination with an aminoglycoside.
    Baruchel A; Hartmann O; Andremont A; Tancrède C
    J Antimicrob Chemother; 1986 Dec; 18 Suppl E():167-73. PubMed ID: 3469190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized multicenter trial of piperacillin/tazobactam versus imipenem/cilastatin in the treatment of severe intra-abdominal infections. Swedish Study Group.
    Eklund AE; Nord CE
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():79-85. PubMed ID: 8383657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Imipenem-cilastatin vs. tobramycin and metronidazole for appendicitis-related infections.
    Uhari M; Seppänen J; Heikkinen E
    Pediatr Infect Dis J; 1992 Jun; 11(6):445-50. PubMed ID: 1608680
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of imipenem-cilastatin in pediatrics.
    Overturf GD
    Pediatr Infect Dis J; 1989 Nov; 8(11):792-4. PubMed ID: 2687788
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic effects of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].
    Tatsumi N; Nin T; Sannomiya Y; Kageyama T; Ohyabu H; Akasaka K; Nasu K; Yonezawa T; Tominaga N; Kitani T
    Jpn J Antibiot; 1989 May; 42(5):1065-76. PubMed ID: 2664253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.